期刊文献+

乳腺癌转移性腹腔积液11例临床病理学分析

Clinicopathological analysis of 11 cases of metastatic peritoneal effusion from breast cancer
暂未订购
导出
摘要 目的 探讨乳腺癌转移性腹腔积液的临床表现、病理特征、免疫表型、鉴别诊断及治疗预后。方法 回顾性分析11例乳腺癌发生腹腔积液转移的临床病理学资料,采用免疫组化EnVision两步法检测ER、PR、HER2、CATA-3等乳腺癌相关抗体的表达,分析其临床病理特征,并复习相关文献。结果 11例患者均为女性,平均年龄约54岁(41~68岁),均有乳腺癌病史,在治疗过程中发生腹腔积液转移,其中7例为浸润性导管癌,3例为浸润性小叶癌,1例为腺泡细胞癌,既往进行过手术、化疗、放疗、靶向治疗、免疫治疗或内分泌治疗等。免疫组化结果显示11例均为乳腺癌来源,分子分型5例为Luminal B型、5例为三阴型、1例为HER2过表达型。其中有3例腹腔积液的分子分型发生改变,例1由Luminal A型变为三阴型,例8及例10由Luminal B型变为三阴型。结论 乳腺癌发生腹腔积液转移罕见,提示预后不良,临床医师需及时提供相关病史,病理医师需要充分关注患者病史,并结合免疫组化进行鉴别,避免漏诊、误诊。
作者 齐贝贝 袁静萍 陈正卓 赵丽娜 Qi Beibei;Yuan Jingping;Chen Zhengzhuo;Zhao Lina(Department of Pathology,Renmin Hospital of Wuhan University,Wuhan 430060)
出处 《临床与实验病理学杂志》 北大核心 2025年第11期1516-1520,共5页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺癌 腹腔积液 转移 免疫组织化学 临床病理特征 breast cancer abdominal fluid metastasis immunohistochemistry clinicopathological features
  • 相关文献

参考文献1

二级参考文献20

  • 1P. Wimberger,H. Gilet,A-K. Gonschior.Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone. Annals of Oncology . 2012
  • 2Kuniaki Shirao,Narikazu Boku,Yasuhide Yamada,Kensei Yamaguchi,Toshihiko Doi,Masahiro Goto,Junichiro Nasu,Tadamichi Denda,Yasuo Hamamoto,Atsuo Takashima,Haruhiko Fukuda,Atsushi Ohtsu,Akira Sawaki,Hogara Nishisaki,Kenji Amagai,Yasuyuki Suzuki.Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)[J]. Japanese Journal of Clinical Oncology . 2013 (10)
  • 3Tom Waddell,Ian Chau,David Cunningham,David Gonzalez,Alicia Frances,Clare Okines,Andrew Wotherspoon,Claire Saffery,Gary Middleton,Jonathan Wadsley,David Ferry,Wasat Mansoor,Tom Crosby,Fareeda Coxon,David Smith,Justin Waters,Timothy Iveson,Stephen Falk,Sarah Slater,Clare Peckitt,Yolanda Barbachano.Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 4Donald Richards,Darren M. Kocs,Alexander I. Spira,A. David McCollum,Sami Diab,Lanny I. Hecker,Allen Cohn,Feng Zhan,Lina Asmar.Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomized phase 2 study[J].European Journal of Cancer.2013
  • 5T. Waddell,M. Verheij,W. Allum,D. Cunningham,A. Cervantes,D. Arnold.Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J].European Journal of Surgical Oncology.2014(5)
  • 6Joji Kitayama,Hironori Ishigami,Hironori Yamaguchi,Hiroharu Yamashita,Shigenobu Emoto,Shoich Kaisaki,Toshiaki Watanabe.Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites[J]. Annals of Surgical Oncology . 2014 (2)
  • 7T. Yamao,Y. Shimada,K. Shirao,A. Ohtsu,N. Ikeda,I. Hyodo.Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Tria. Japanese Journal of Clinical Oncology . 2004
  • 8Lin Shen,Jin Li,Jianming Xu,Hongming Pan,Guanghai Dai,Shukui Qin,Liwei Wang,Jinwan Wang,Zhenzhou Yang,Yongqian Shu,Ruihua Xu,Lei Chen,Yunpeng Liu,Shiying Yu,Lilian Bu,Yongzhe Piao.Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)[J]. Gastric Cancer . 2015 (1)
  • 9Simon C. Blackburn,Michael P. Stanton.Anatomy and physiology of the peritoneum[J]. Seminars in Pediatric Surgery . 2014 (6)
  • 10Nian Fang,Hui-Qing Zhang,Bo He,Mei Xie,Shan Lu,Yi-Ye Wan,Nong-Rong Wang.Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites[J]. Tumor Biology . 2014 (4)

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部